Treatment of hyperlipoproteinemia with pantethine: A review and analysis of efficacy and tolerability

Nutrition Research

Volumn 25, Issue 4, 2005, Pages 319-333

  McRae, Marc P ^a  

^a NATIONAL UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Cholesterol; Hyperlipidemia; Hyperlipoproteinemia; Lipids; Pantethine

Indexed keywords

ACIPIMOX; BEZAFIBRATE; CHOLESTEROL; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PANTETHINE; TRIACYLGLYCEROL;

ADULT; AGED; CALCULATION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DIURESIS; DRUG EFFICACY; DRUG TOLERABILITY; HEART PALPITATION; HEARTBURN; HUMAN; HYPERLIPOPROTEINEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MEDLINE; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; PRURITUS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; SAMPLE SIZE; SIDE EFFECT; STOMACH DISEASE; TIME SERIES ANALYSIS; VOMITING;

EID: 16844363076     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2004.12.009     Document Type: Article

References (55)

1. The World Health Organization CVD prevention and control: missed opportunities www.who.int/cardiovascular_disease/prevention_contol/en/ [accessed August 2003]
2. J. LaRosa Understanding risk in hypercholesterolemia Clin Cardiol 26 Suppl. I 2003 I3 I6
3. W. Castelli, R. Garrison, P. Wilson, R. Abbott, S. Kalousdian, and W. Kannel Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study JAMA 256 1986 2835 2838
4. American Heart Association Heart disease and stroke statistics-2003 update 2002 American Heart Association Dallas (Tex)
5. A. Gotto Treating hypercholesterolemia: looking forward Clin Cardiol 26 Suppl. I 2003 I21 I28
6. C. Hodel Myopathy and rhabdomyolysis with lipid lowering drugs Toxicol Lett 128 2002 159 168
7. M. Davidson Combination therapy for dyslipidemia: safety and regulatory considerations Am J Cardiol 90 Suppl. 2002 k50 k60
8. R. Volpe, L. Niittynen, R. Korpela, C. Sirtori, A. Bucci, and N. Fraone Effects of yoghurt enriched with plant sterols on serum lipids in patients with moderate hypercholesterolaemia Br J Nutr 86 2001 233 239
9. J. Keenan Treatment of patients with lipid disorders in the primary care setting: new treatment guidelines and their implications South Med J 96 2003 266 275
10. G. Kelly Pantethine: a review of its biochemistry and therapeutic applications Altern Med Rev 2 1997 365 377
11. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults: executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) JAMA 285 2001 2486 2497
12. F. Coronel, F. Tornero, J. Torrente, P. Naranjo, P. DeOleo, and M. Marcia Treatment of hyperlipidemia in diabetic patients on dialysis with a physiological substance Am J Nephrol 11 1991 32 36
13. L. Tonutti, C. Taboga, and C. Noacco Confronto dell'efficacia di pantetina, acipimox e bezafibato sui lipidi plasmatici ed indice di rischio cardiovascolare in diabetici dislipidemici Minerva Med 82 1991 657 663
14. P. Binaghi, G. Cellina, G. LoCicero, F. Bruschi, E. Porcaro, and M. Penotti Evaluation of the hypocholesterolemic activity of pantethine in perimenopausal women Minerva Med 81 1990 475 479
15. Z. Lu A double-blind clinical trial: the effects of pantethine on serum lipids in patients with hyperlipidemia Zhonghua Xin Xue Guan Bing Za Zhi 17 1989 221 223
16. M. Eto, K. Watanabe, N. Chonan, and K. Ishii Lowering effect of pantethine on plasma beta-thromboglobulin and lipids in diabetes mellitus Artery 15 1987 1 12
17. D. Prisco, P. Rogasi, M. Matucci, R. Paniccia, R. Abbate, and G. Gensini Effect of oral treatment with pantethine on platelet and plasma phospholipids in type IIa hyperlipoproteinemia J Vasc Dis 38 1987 241 247
18. F. Bellani, R. Colnago, M. Meregalli, P. Scarpazza, O. Sesia, and C. Donati Treatment of hyperlipidemias complicated by cardiovascular diseases in the elderly: results of an open short-term study with pantethine Curr Ther Res 40 1986 912 916
19. S. Bertolini, C. Donati, N. Elicio, A. Daga, S. Cuzzolaro, and A. Marcenaro Lipoprotein changes induced by pantethine in hyperlipoproteinemic patients: adults and children Int J Clin Pharmacol Ther Toxicol 24 1986 630 637
20. C. Donati, G. Barbi, G. Cairo, G.F. Prati, and E. Degli Esposti Pantethine improves the lipid abnormalities of chronic hemodialysis patients: results of a multicenter clinical trial Clin Nephrol 25 1986 70 74
21. L. Arsenio, P. Bodria, G. Magnati, A. Strata, and R. Trovato Effectiveness of long-term treatment with pantethine in patients with dyslipidemia Clin Ther 8 1986 537 545
22. S. Giannini, N. Forti, F. DiRienzo, J. Campanari, and E. Ziliotto Efeitos da pantetina sobrelipides sangineos Arq Bras Cardiol 46 1986 283 289
23. F. Bergesio, R. Ciuti, D. Innocenti, G. Galli, and V. Frizzi Impiego della pantetina nella dislipidemia dell'uremico cronico in trattamento dialitico G Clin Med 66 1985 433 440
24. G.F. Gensini, D. Prisco, P.G. Rogasi, M. Matucci, and G.G. Neri Serneri Changes in fatty acid composition of the single platelet phospholipids induced by pantethine treatment Int J Clin Pharmacol Res 5 1985 309 318
25. L. Cattin, P. DaCol, M. Fonda, M. Mameli, L. Pilotto, and D. Vanuzzo Treatment of hypercholesterolemia with pantethine and fenofibrate: an open randomized study on 43 subjects Curr Ther Res 38 1985 386 395
26. A. Postiglione, P. Rubba, U. Cicerano, I. Chierchia, and M. Mancini Pantethine versus fenofibrate in the treatment of type II hyperlipoproteinemia Monogr Atheroscler 13 1985 145 148
27. G. Seghieri, G. Maffucci, G. Toscano, F. Santoni, S. Tuci, and L. DeGiorgio Effetto della terapia con pantetina in uremici cronici emodializzati con iperlipoproteinemia di tipo IV G Clin Med 66 1985 187 192
28. L. Arsenio, S. Caronna, M. Lateana, G. Magnati, A. Strata, and G. Zammarchi Iperlipidemia diabete ed aterosclerosi: efficacia del trattamento con pantetina Acta Biomed Ateneo Parmense 55 1984 25 42
29. O. Bosello, L. Cominacini, U. Garrbin, F. Ferrari, I. Zocca, and A. Davoli Changes in the very low density lipoprotein distribution of apolipoproteins C-III2, C-III1, C-III0, C-II and apolipoprotein E after pantethine administration Acta Ther 10 1984 421 430
30. P. Da Col, L. Cattin, M. Fonda, M. Mameli, and F. Feruglio Pantethine in the treatment of hypercholesterolemia: a randomized double-blind trial versus tiadenol Curr Ther Res 36 1984 314 321
31. A. Gaddi, G.C. Descovich, G. Noseda, C. Fragiacomo, L. Colombo, and A. Craveri Controlled evaluation of pantethine, a natural hypolipidemic compound, in patients with different forms of hyperlipoproteinemia Atherosclerosis 50 1984 73 83
32. R. Miccoli, P. Marchetti, T. Sampietro, L. Benzi, M. Tognarelli, and R. Navalesi Effects of pantethine on lipids and apolipoproteins in hypercholesterolemic diabetic and non-diabetic patients Curr Ther Res 36 1984 545 549
33. M. Maioli, A. Pacifico, and G. Cherchi Effect of pantethine on the subfractions of HDL in dyslipidemic patients Curr Ther Res 35 1984 307 311
34. G. Ranieri, R. Chiarappa, M. Balestrazzi, G. Gattulli, and R. DeCesaris Effect of pantethine on lipids and lipoproteins in man Acta Ther 10 1984 219 227
35. F. Galeone, A. Scalabrino, F. Giuntoli, A. Birindelli, G. Panigada, and A. Rossi The lipid lowering effect of pantethine in hyperlipidemic patients: a clinical investigation Curr Ther Res 34 1983 383 390
36. A. Murai, T. Miyahara, T. Tanaka, Y. Sako, N. Nishimura, and M. Kameyama The effects of pantethine on lipid and lipoprotein abnormalities in survivors of cerebral infarction Artery 12 1983 234 243
37. P. Avogaro, G. Bittolo, and M. Fusello Effect of pantethine on lipids, lipoproteins and apolipoproteins in man Curr Ther Res 33 1983 488 493
38. G. Maggi, C. Donati, and G. Criscuoli Pantethine: a physiological lipomodulating agent in the treatment of hyperlipidemias Curr Ther Res 32 1982 380 386
39. K. Hiramatsu, H. Nozaki, and S. Arimori Influence of pantethine on platelet volume, microviscosity, lipid composition and functions in diabetes mellitus with hyperlipidemia Tokai J Exp Clin Med 6 1981 49 57
40. C. Wittwer, C. Graves, M. Peterson, E. Jorgensen, D. Wilson, and J. Thoene Pantethine lipomodulation: evidence for cysteamine mediation in vitro and in vivo Atherosclerosis 68 1987 41 49
41. G. Cighetti, M. DelPuppo, R. Paroni, E. Fiorica, and M. Kienle Pantethine inhibits cholesterol and fatty acid synthesis and stimulates carbon dioxide formation in isolated rat hepatocytes J Lipid Res 28 1987 152 161
42. S. Ranganathan, R. Jackson, and J. Harmony Effect of pantethine on the biosynthesis of cholesterol in human skin fibroblasts Atherosclerosis 44 1982 261 273
43. M. Tomikawa, T. Nakayasu, K. Tawara, K. Kameda, and Y. Abiko Effect of pantethine on lipoprotein profiles and HDL subfractions in experimentally hypercholesterolemic rabbits Atherocsclerosis 41 1982 267 277
44. M. Shinomiya, N. Matsuoka, K. Shirai, N. Morisaki, N. Sasaki, and S. Murano Effect of pantethine on cholesterol ester metabolism in rat arterial wall Atherosclerosis 36 1980 75 80
45. P. Carrara, L. Matturri, M. Galbussera, M. Lovati, G. Franceschini, and C. Sirtori Pantethine reduces plasma cholesterol and the severity of arterial lesions in experimental hypercholesterolemic rabbits Atherosclerosis 53 1984 255 264
46. G. Bon, G. Cazzolato, S. Zago, and P. Avogaro Effects of pantethine on in-vitro peroxidation of low density lipoproteins Atherosclerosis 57 1985 99 106
47. Global Cardiovascular Infobase: epidemiological profiles of cardiovascular and cerebrovascular diseases in the world www.cvdinfobase.ca/ [accessed August 2003]
48. M. McCarty Inhibition of acetyl-CoA carboxylase by cystamine may mediate the hypotriglyceridemic activity of pantethine Med Hypotheses 56 2001 314 317
49. C. Donati, R. Bertieri, and G. Barbi Pantetina, diabete e aterosclerosi: indagine clinica su 1045 pazienti Clin Ther 128 1989 411 422
50. C. Packard Overview of fenofibrate Eur Heart J 19 Suppl. A 1998 a62 a65
51. M. Triguero Literature review on fenofibrate An Med Interna 10 1993 195 199
52. J. Balfour, D. McTavish, and R. Heel Fenofibrate: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia Drugs 40 1990 260 290
53. K. Goa, L. Barradell, and G. Plosker Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia Drugs 52 1996 725 753
54. T. Serra, M. Gavelii, E. Vitaliano, G. Santini, A. Catalano, and F. Rossi Therapy of hypercholesterolemia and hypertriglyceridemia: comparison of the lipid-lowering effect of simvastatin and tiadenol Clin Ther 132 1990 307 313
55. Y. Matsuzawa, T. Kita, H. Mabuchi, M. Matsuzaki, N. Nakaya, and S. Oikawa Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients Circ J 67 2003 287 294